Ptyalism & Pseudoptyalism

Ptyalism & Pseudoptyalism

Diagnostic Tree Internal Medicine Peer Reviewed Julie Allen, BVMS, MS, DACVIM (Small Animal) Ptyalism & Antech Diagnostics Pseudoptyalism Drooling* Ptyalism (excessive saliva** production) Pseudoptyalism (inability to swallow normal saliva production; drooling**) History & examination • Complete physical examination, evaluating salivary gland size and symmetry • Full neurologic examination • Breed: Giant breeds (eg, St. Bernard) or Yorkshire and Maltese terriers (increased PSS incidence) • Age: Young animals likely to ingest toxins/FBs or have congenital issues; neoplasia likely in older animals • History of vaccination (eg, rabies, calicivirus) or trauma (eg, electric cord injury) • Exposure to toxins, medications, topical products • Duration: Acute (eg, FB) vs chronic (eg, neoplasm) • Discoloration of saliva (eg, blood, purulent discharge) suggestive of oral problem • Halitosis may indicate oral, esophageal, or gastric disease • Pawing at face/mouth may indicate orofacial pain, hypocalcemia • Change in eating behavior: Dropping food, chewing on one side of the mouth, pseudoanorexia or hyporexia • Diet (eg, high-protein) can cause drooling because of precipitation of HE in patients with liver dysfunction • Other GI (ie, retching, regurgitation, vomiting, weight loss) or neurologic signs (ie, seizures, gagging, dysphagia) Known toxin Known medication exposure Toxicity Medication reaction • Household cleaners • Medications/topical products given topically or PO • Plants/trees (eg, Kentucky coffee tree, poinsettia) (eg, selamectin, moxidectin–imidacloprid) • Insecticide/pesticide (eg, boric acid, aldicarb) • Cholinergic drugs (eg, bethanechol), anticholinesterase • Rodenticide (eg, zinc phosphide) drugs (eg, pyridostigmine), cholinesterase inhibitors • Illicit drugs (eg, cocaine, amphetamines) (eg, OP) • Animal venoms (eg, black widow spider, scorpion, • Pyrethrins/pyrethroids toads [Bufo spp], coral snake, sea hare [Aplysia spp]) • Ivermectin • Human sleep aids (eg, zolpidem) • Bitter drugs • Mushrooms (eg, Amanita muscaria) • Metaldehyde • Human tricyclic antidepressants (eg, clozapine) • 5-hydroxytryptophan (ie, Griffonia seed extract) • Discontinue medication • Supportive care • Depends on toxin exposure • Dilution if caustic agent * Rabies should always be considered in patients presenting with • Decontamination (eg, activated charcoal) drooling. • Supportive care • Specific antidote (if available) ** Distinction between ptyalism and pseudoptyalism is not absolute; oropharyngeal and CNS diseases can result in increased salivary production and inability to swallow. † HE management includes low-protein diet, enemas, oral antibiotics, lactulose, zinc supplementation, supportive care. AChR Ab = acetylcholine receptor antibody, FB = foreign body, FNA = fine-needle aspiration, HE = hepatic encephalopathy, OP = organophos- phates, PSS = portosystemic shunt, SCC = squamous cell carcinoma, T4 = thyroxine 12 cliniciansbrief.com • June 2014 • Periodontal disease • Stomatitis (eg, calicivirus, FeLV/FIV, caustic agent) • Depends on underlying disease • Immune-mediated disease (eg, pemphigus) • Dental cleaning/extractions Oral cavity abnormal • Tongue lesion (eg, linear FB), glossitis • Antiinflammatory/ (eg, uremia, caustic agent), tumor immunomodulatory therapy • Oropharyngeal disease (eg, tonsillar SCC) • Surgical resection/correction • Lip fold abnormalities • Faucitis Oral cavity normal Neurologic, GI signs, or abnormal salivary glands? No other findings? Physiologic Minimum database (CBC, chemistry panel, • Response to feeding T4, UA) • Hyperthermia • Excitement • Purring Additional diagnostics based on findings No other findings • Bile acids (if HE suspected) • FeLV/FIV testing • AChR Ab test (if myasthenia gravis possible) • FNA/biopsy of lesions (mucocutaneous, oropharyngeal, lingual) Idiopathic or nonresponsive • FNA/biopsy of salivary glands • Radiography (oral cavity, neck, thorax, abdomen) • Abdominal ultrasonography • Portal scintigraphy • Fluoroscopic evaluation of swallowing • Atropine or glycopyrrolate to decrease salivary flow • Preventive measures for moist dermatitis • Fluid support (if dehydrated) • Salivary gland removal GI disease Neurologic disease Abnormal salivary glands • Any disease resulting • Seizures • Sialadenitis, necrotizing sialo- in nausea • Infectious disease (eg, metaplasia (ie, inflammation of • Esophageal disease rabies, pseudorabies, salivary glands) • Gastric dilatation– tetanus, botulism) • Sialadenosis–idiopathic non- volvulus • Myasthenia gravis inflammatory salivary gland • Gastric ulceration • Idiopathic trigeminal enlargement (may be form • Renal failure neuritis of limbic epilepsy) • Hepatic failure (HE; • Lesions of cranial nerves • Salivary gland neoplasia particularly in cats) IX, X, XII • Salivary mucocele • Treat underlying disease • Anticonvulsants • Sialadenitis: If immune Diagnosis • Antiemetics, antacids • Other therapies, mediated, treat with for nausea depending on diagnosis Differential immunosuppressive dose of Diagnosis • HE management† corticosteroids ± phenobarbital • Sialadenosis: Phenobarbital, Investigation sclerotherapy • Mucocele/neoplasia: Surgical Treatment management Results June 2014 • Clinician’s Brief 13.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us